JM, V., RE, G., J, G., V, C., RI, L., E, V., . . . ME, F. (2024). Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60. Pharmaceuticals (Basel, Switzerland), 17(10), . https://doi.org/10.3390/ph17101374
Chicago Style (17th ed.) CitationJM, Viveros-Paredes, González-Castañeda RE, Gertsch J, Chaparro-Huerta V, López-Roa RI, Vázquez-Valls E, Beas-Zarate C, Camins-Espuny A, and Flores-Soto ME. "Correction: Viveros-Paredes Et Al. Neuroprotective Effects of β-Caryophyllene Against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60." Pharmaceuticals (Basel, Switzerland) 17, no. 10 (2024). https://doi.org/10.3390/ph17101374.
MLA (9th ed.) CitationJM, Viveros-Paredes, et al. "Correction: Viveros-Paredes Et Al. Neuroprotective Effects of β-Caryophyllene Against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60." Pharmaceuticals (Basel, Switzerland), vol. 17, no. 10, 2024, https://doi.org/10.3390/ph17101374.
